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Abstract
Background: Vitamin D deficiency and infertility are two important health problems in
Iran. Some studies suggest that vitamin Dmay influence Anti-Müllerian hormone (AMH)
and antral follicle count (AFC) as an ovarian reserve.
Objective: The present study aimed to investigate the impact of vitamin D on AMH
serum concentrations/AFC.
Materials and Methods: Three hundred and five infertile women referred to the IVF
Unit of Yas hospital, between July and December 2017, were enrolled in this cross-
sectional study. The demographic characteristics of the participants, as well as the
serum levels of vitamin D, AMH, and ultrasonic examination of AFC were recorded.
Results: Finally, 287 infertile women were included in the analysis with a mean age of
29.95± 4.73 yr (18-45 yr) and amean Bodymass indexof 25.11± 4.41 kg/m2. Themedian
AMH and vitamin D levels were 3.20 and 22.82 ng/ml, respectively. Considering the
cut-off level of 20 ng/ml, 58.7% were vitamin D deficient. Regression analysis showed
no association between AMH and vitamin D levels (p = 0.161), even after adjusting for
baseline variables (p = 0.182). A total of 120 patients had an AFC < 6 and 164 ≥ 6, which
was not statistically different between the groups with normal level or deficient vitamin
D (p = 0.133).
Conclusion: The present cross-sectional study showed no significant association
between serum levels of vitamin D and AMH or AFC in infertile women, even after
adjusting for baseline variables.
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1. Introduction
Vitamin D, a fat-soluble vitamin is absorbed
by the sunlight and considered as a sunshine
hormone. It has significant roles in different parts of
the body, suggested to be due to the expression
of vitamin D receptor (VDR) on different organs.
Hence, it plays a significant role in insulin resistance
(1), cancers, and a variety of chronic diseases (2,
3). Despite appropriate sun light supply in Iran, a
high prevalence of vitamin D hypovitaminosis was
reported in the Iranian population, especially in
women (4).
As a result, VDR is also expressed on the male
and female reproductive systems, studies suggest
the role of vitamin D in infertility (5), with a lifetime
prevalence of about 25% (6). Several studies
have thus addressed the association of vitamin
D with different markers indicating infertility (7,
8). Ovarian reserve can be measured by antral
follicle count (AFC), but it requires ultrasound
examination and may be biased (9). Anti-Müllerian
hormone (AMH), a member of the TGF-beta
(transforming growth factor-beta) superfamily
of proteins, which produced by granulosa cells
and secreted by pre-antral and antral follicles
(10), has been suggested as a better index of
ovarian reserve of follicles than AFC (11) and is
mainly used in assisted reproductive technology.
It has been suggested that vitamin D changes
AMH signaling by downregulation the expression
of AMH receptor-II gene (12), follicle-stimulating
hormone (FSH) sensitivity and progesterone
production. Moreover it has an important role
in follicular development, differentiation, and
luteinization (13).
Although the association of vitamin D and AMH
levels have been proposed by animal studies
(14, 15), clinical human studies failed to prove
such an association (16, 17) and some have
reported variable association based on season
or sex (18). In addition, various studies have
studied the association of vitamin D and AMH with
different causes of infertility, like endometriosis and
polycystic ovarian syndrome (PCOS) (19) and have
shown the significant role of vitamin D, while other
studies have suggested no association (20).
Due to the inconsistency of the results of studies
testing this hypothesis and the significance of
hypovitaminosis D in Iran, the present study aimed
to investigate the association between vitamin D
and AMH/AFC on an Iranian population.
2. Materials and Methods
2.1. Study design
The present prospective cross-sectional study
investigated all infertile women referred to the IVF
Unit of YAS Hospital from July to December 2017
for fertility evaluation.
The sample size of this study was calculated
at 305, based on the study of Drakopoulos
and colleagues (16), considering α = 0.05 and
power of 80%. Patients who met the following
inclusion criteria were enrolled into the study
by convenient sampling method until saturation
of the sample size: women, aged 18 to 45 yr,
diagnosed with infertility by the gynecologist,
defined as no conception after 12 months of
no contraceptive methods, who did not use any
vitamin supplements, and gave written consent
for participation into this study. Women with any
underlying endocrine or metabolic disease were
excluded from the study. Also, any patient who
refused to continue the study or did not complete
the study was excluded.
After confirmation of the diagnosis, the
characteristics of all eligible patients were
recorded in checklists designed for this study.
The recorded variables included age, weight, and
height (for calculation of body mass index [BMI]),
etiology of infertility, and smoking status. The
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measurement of patients’ height and weight were
performed by standard protocols in the same clinic
and recorded in the checklist.
Then, patients were referred for further serum
laboratory tests and ultrasound examination. One
non-fasting blood sample was taken from patients
from the left hand’s cubital vein in the sitting
position that was sent to the laboratory of the
hospital. The samples were centrifuged and stored
at 20ºC. Vitamin D status was measured by
assessing serum levels of 25 OH-D in frozen
samples using enzyme immune assay (ELISA,
Accu-Bind, Monobind, Inc, Lake Forest, USA). The
sensitivity of the 25 OH-D vitamin D Accu-Bind
ELISA test system is 0.67ng/ml. The intraassay and
interassay variation coefficients were 3.95 % and
5.62%, respectively. The AMH was measured by
the ELC method using Roche device (Cobas E411,
made in Germany). AFC was measured in early
follicular phase.
Then, patients were referred to the radiology
clinic of the hospital for a vaginal ultrasound. All
ultrasound examinations were performed by one
radiologist, who counted the follicles with 2_9 mm
diameters and recorded them as AFC.
The results of laboratory and ultrasound
measurements were recorded in the checklist
and used for analysis. After data collection, the
patients were scheduled for the treatment plan,
based on the gynecologists’ opinion, which was
recorded in the checklist and used for analysis.
2.2. Ethical consideration
The study was approved by the Ethics
Committee of Tehran University of Medical
Sciences (Code: IR.TUMS.MEDECINE.1396-
3430). Before recruitment, the design and
objectives of the study were explained to all
participants and those who were willing to
participate in the study signed the written informed
consent. No additional costs were imposed on
the patients and all ethical principles of the
latest version of the Declaration of Helsinki
on human studies were met throughout the
study.
2.3. Statistical analysis
The results of quantitative variables were
reported by the median, mean ± standard
deviation (SD), and categorical variables by
frequency (percentage). Kolmogorov-Smirnov test
was used to assess the normal distribution of data,
the results of which indicated that distribution
of AMH and Vitamin D levels were not normal,
therefore nonparametric tests, such as Mann-
Whitney U-test, were used for their analysis. Other
continuous variables were compared using T-
test. Categorical variables were compared using
the chi-square test. For a better comparison of
variables with vitamin D levels, this continuous
variable was considered as two categories
(normal level or deficient) based on the cut-
off point of 20 ng/ml (21). The association of
variables was tested by Pearson’s correlation
coefficient and multiple regression model. For
all statistical analysis, the statistical software IBM
SPSS Statistics for Windows version 21.0 (IBM
Corp. 2012. Armonk, NY: IBM Corp) was used.
P-values < 0.05 were considered statistically
significant.
3. Results
A total of 305 infertile women were included in
the study. Eighteen patients did not complete the
study. Finally, 287 infertile women were included
in the analysis. Patients’ age ranged from 18-
45 yr with a mean ± SD of 29.95 ± 4.73 yr.
The demographic and clinical characteristics of
participants are shown in table I. Median AMH
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and vitamin D levels are also shown in table
I. Considering the cut-off level of 20 ng/ml,
patients were categorized into two groups and
demographics and AMH levels were compared
between the groups. As shown in table I, 58.7%
were vitamin D deficient and the rest were not,
and there were no difference between the groups
in terms of age, BMI, and AMH levels. Also,
serum vitamin D levels were not different in
Summer compared to Autumn (p > 0.05) (Table
I).
The AFC levels (categorized as < 6 and ≥ 6) are
compared with AMH and vitamin D sufficiency in
table II. As demonstrated, there was no statistically
significant difference between the groups with
normal level or deficient vitamin D, while median
AMH levels were significantly higher in AFC levels
≥ 6 (p < 0.001). Regression analysis showed no
statistically significant association between AMH
and vitamin D levels (Spearman’s r = -0.083, 95%
CI:-0.69-0.011, p = 0.161) (Figure 1). After adjusting
for potential confounders (age and BMI), the results
of multiple linear regression analysis showed no
association between serum levels of vitamin D
and AMH levels (Spearman’s r = -0.080, p =
0.182).
Table I. Comparison of demographic and clinical characteristics of participants according to vitamin D sufficiency
Variable Total Vitamin D ng/ml P-value
> 20 ≤ 20
Age (yr)* 29.95 ± 4.73 30.14 ± 4.59 29.68 ± 4.96 0.551†
BMI (Kg/m2)* 25.11 ± 4.41 25.11 ± 4.18 25.10 ± 4.10 0.936†
Season**
Summer 137 (47.7%) 79 (27.5%) 58 (20.2%)
Autumn 150 (52.3) 87 (30.3%) 63 (21.9%) 0.819
x
AMH, ng/ml*** 3.20 2.70 3.80 0.93‡
*Data presented as Mean ± SD **Data presented as n (%) ****Data presented as median
† t test ‡Chi-square xANOVA BMI: Body mass index AMH: Anti-Müllerian hormone
Table II. Comparison of AFC value according to median anti-Müllerian hormone and the frequency of the studied patients in
different categories of 25-OH vitamin D
Category Total count Median AMH P-value† Vitamin D > 20
ng/ml, No
Vitamin D < 20
ng/ml, No
P-value†
AFC < 6 120 1.62 74 46
AFC ≥ 6 164 4.26 < 0.001 89 75 0.133
†The results of ANOVA AFC: Antral follicle count AMH: Anti-Müllerian hormone
Figure 1. Correlations plot between 25-OH vitamin D and anti-Müllerian hormone (AMH).
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4. Discussion
The results of the present study revealed that
a majority of our patients were in vitamin D
deficiency zone (< 20 ng/ml). The median vitamin
D level was close to the cut- off of deficiency
.These results are consistent in line with the
results of previous studies, indicating a high
prevalence of vitamin D deficiency in the Iranian
population, especially women (22-24). Another
study in Tehran reported that 54% of women
living in Tehran had a serum vitamin D level
of < 10 ng/ml and 32% of them had a serum
vitamin D level of 10-20 ng/ml (22). One study
on reproductive age women who were residences
of Tehran, has also shown that more than 85%
had a serum vitamin D level of less than 20
ng/ml (25). Although the prevalence rate in the
aforementioned studies are higher than that of
ours, their results suggest a high prevalence of
vitamin D deficiency in this population, which
confirms the results of our study. This is while
Tehran, located in 36°21”N, has a mean sun
exposure of 8 hr / day. However, women are
mainly stay indoors (23). In addition, air pollution
is considered one of the causes of the high
prevalence of vitamin D deficiency in women living
in Tehran (22).
Considering the fact that vitamin D deficiency
is associated with several diseases and can
predispose patients to some diseases or
deteriorate the disease status, it is important
to pay attention to vitamin D levels of patients (26).
Infertility is one of the diseases associated with
vitamin D deficiency and women with infertility
are expected to have a higher prevalence of
vitamin D deficiency, which emphasizes the
significance of paying attention to the serum level
of vitamin D in infertile women and appropriate
supplementation of deficient cases (27, 28).
Therefore, in the present study, we investigated
the association of vitamin D deficiency with their
ovarian reserve in infertile women. In our study,
AMH was recorded in 287 infertile women, who
were referred to a specialized infertility clinic and
the results showed a median AMH level of 3.20
ng/ml, significantly associated with lower AFC
levels. This association suggests the value of
AMH in predicting follicle count, as a simpler test,
which confirms the results of previous studies (29,
30).
For testing the main hypothesis of the present
study, the association of AMH and AFC levels
with vitamin D levels were tested. The results of
our analysis indicated that neither AMH nor AFC
levels differed between groups with deficient or
sufficient vitamin D levels. Also, regression analysis
showed no association between AMH and vitamin
D levels. These results suggested that serum levels
of vitamin D were not related to AMH levels. This
hypothesis has been evaluated by few studies
previously. Pearce and colleagues, in their study
investigated the association of AMH with vitamin
D in 340 women (58 with PCOS and 282 ovulatory
women) who aged below 40 yr; the results of this
study reported no difference in the serum level of
vitamin D between the two groups and indicated
no association between AMH and vitamin D levels
in neither groups (17). These results are similar to
that of our study, suggesting that the serum levels
of vitamin D are not associated with AMH; although
we evaluated infertile women with any cause. As
AMH is important in pathophysiology of PCOS
(19), the results of our study are comparable to
those studying PCOS (13, 19). The literature review
also suggests that vitamin D supplementation
can neither improve AMH production in women
with PCOS (13) nor does it reduce the risk of
endometriosis (31). Molecular investigation has
also showed that VDR polymorphism did not
cause endometriosis or infertility (20). These results
confirm the general conclusion of our study,
indicating no association between vitamin D and
infertility, although in our study, we did not examine
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the cause of infertility and nor did we separate
the results according to the cause of infertility. In
addition to the BMI and seasonal changes, which
we considered for adjusting the results accordingly,
there are several other factors that can affect the
serum levels of vitamin D.
As far as we are concerned, there are very
few studies that reported a positive association
between AMH and serum levels of vitamin D.
In the study by Dennis et al., 113 adult men,
33 women of reproductive age, and 74 young
boys were investigated, and the results showed
that vitamin D is a regulator of AMH in men
and women but not in boys and recorded a
positive association between AMH and serum
levels of vitamin D (18). However, this study had
some methodological problems such as small
sample size. Therefore, the results may not be
conclusive. In another Iranian study, 30 infertile
women were treated with 50,000 IU weekly
vitamin D supplements for three months and the
results showed a significant increase in AMH and
vitamin D levels after treatment; according to the
results of this study, AMH levels increased from
0.513 ng/ml before treatment to 1.048 ng/ml after
treatment in women with vitamin D deficiency
(32). Although they reported increased AMH, the
post-treatment AMH levels were still below the
lower limit of AMH (< 1.5 ng/ml) (31), while in the
present study, the median AMH of our participants
was within the normal range. Therefore, the
difference in the clinical characteristic of patients
could be the underlying factor for the differences
between studies. Furthermore, the discrepancy
among the results of studies might be due to the
seasonal changes in vitamin D values, different
measurement techniques, and different causes of
infertility that can cause differences in vitamin D
levels.
Although the present study investigated the
association of AMH and FSH with serum levels
of vitamin D in a sufficient sample of infertile
women, this study could have several limitations.
Firstly, the cross-sectional nature of the study
that limited the generalizability of the results and
reporting the short- and long-term follow-up results
of participants. Secondly, there are a wide range
of variables that can affect the serum level of
vitamin D, as well as AMH levels, which can affect
the results of this study. Although the cause of
infertility may change the serum levels of vitamin
D, it was not within the study objectives and its
assessment requires further studies. Meanwhile,
we evaluated all samples with one kit and using
one device to reduce the confounding effect of
different measurement techniques on serum levels
of vitamin D and one radiologist interpreted all
AFC levels, performed in one center, to reduce the
confounding effect of these variables. Finally, we
adjusted the results for BMI and seasonal changes
in serum levels of vitamin D.
5. Conclusion
In conclusion, the present cross-sectional study
showed a high prevalence of vitamin D deficiency
in the sample of 287 infertile women, referred
for treatment; however, there was no significant
association between the serum levels of vitamin
D and AMH or AFC in infertile women, even after
adjusting for confounders. Studying other indices
of reproduction/ovarian reserve and controlling
the effect of confounders in future randomized
clinical trials can investigate this hypothesis more
accurately and suggest the therapeutic efficacy of
vitamin D supplementation on infertility.
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